Conditioned blood reperfusion markedly enhances neurologic recovery after prolonged cerebral ischemia

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 6, 2003, Pages 1851-1858

  Allen, Bradley S ^a   Castellá, Manuel ^b   Buckberg, Gerald D ^b   Tan, Zhongtou ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; ENDOTHELIN 1; FREE RADICAL; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; COMPLEMENT ACTIVATION; CONDITIONING; CONTROLLED STUDY; HEMODYNAMICS; NERVE FUNCTION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; SCORING SYSTEM; SWINE; TISSUE PERFUSION; WARMING;

EID: 0346434098     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)01295-9     Document Type: Article

References (35)

1. Allen BS, Okamoto F, Buckberg GD, et al. Studies of controlled reperfusion after ischemia XV: immediate functional recovery after 6 hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate. J Thorac Cardiovasc Surg. 1986;92:S621-35.
2. Buckberg GD, Allen BS. Myocardial protection management during adult cardiac operations. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, editors. Glenn's thoracic and cardiovascular surgery. 6th ed. Stamford, CT: Appleton & Lange; 1995. p. 1653-87.
3. Boyle JR, Pohlman TH, Cornejo CJ, Verrier ED. Ischemia-reperfusion injury. Ann Thorac Surg. 1997;64:S24-30.
4. Allen BS, Barth MJ, Ilbawi M. Pediatric myocardial protection: an overview. Semin Thorac Cardiovasc Surg. 2001;13:56-72.
5. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998;38:291-300.
6. Beyersdorf F, Mitrev, Z, Ihnken K, et al. Controlled limb reperfusion in patients having cardiac operations. J Thorac Cardiovasc Surg. 1996;111:873-81.
7. Halldorsson A, Kronon M, Allen BS, et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. J Thorac Cardiovasc Surg. 1998;115:415-25.
8. Kronon MT, Allen BS, Rahman SK, et al. Reducing postischemic reperfusion damage in neonates using a terminal warm substrate enriched blood cardioplegic reperfusate. Ann Thorac Surg. 2000;70:765-70.
9. Julia P, Haab F, Sabatier B, et al. Improvement of postischemic kidney function by reperfusion with a specifically developed solution (BT01). Ann Vasc Surg. 1995;9(Suppl):81-8,
10. Halldorsson A, Kronon M, Allen BS, et al. Controlled reperfusion prevents pulmonary injury after 24-hours of lung preservation. Ann Thorac Surg. 1998;66:877-85.
11. Allen BS. The role of leukodepletion in myocardial, pulmonary and lower extremity ischemia. Perfusion. 2002;17:11-22.
12. Allen BS, Buckberg GD, Aeberhard E, Ignarro LJ. Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate; a new concept. J Thorac Cardiovasc Surg. 2003;125:628-32.
13. Byrne J, Appleyard R, Lee C, et al. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg. 1992;103:66-72.
14. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg. 1996;112:494-500.
15. Morioka K, Muraoka R, Chiba Y, et al. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;111:45-54.
16. Chiba Y, Morioka K, Muraoka R, et al. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 1998;65:107-13.
17. Kronon MT, Allen BS, Halldorsson A, Rahman SK, Wang T, Ilbawi M. L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts. J Thorac Cardiovasc Surg. 1999;118:665-73.
18. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation. 1998;97:2259-67.
19. Gardinali M, Conciato L, Cafaro C, Agostoni A. Complement system in coronary heart disease: a review. Immunopharmacology. 1995;30:105-17.
20. Rinder CS, Rinder HM, Smith BRE. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 1995;96:1564-72.
21. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selections. Circulation. 1998;98:1322-8.
22. Buerke M, Prufer D, Dahm M, Oelert H, Merer J, Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther. 1998;286:429-38.
23. Ko W, Lang D, Hawes AS, Zelano JA, Isom OW, Krieger KH. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. J Surg Res. 1993;55:504-15.
24. Haaland K, Orderud WJ, Thoresen M. The piglet as a model for cerebral circulation: an angiographic study. Biol Neonate. 1995;68:75-80.
25. Patel MB, Kilgore KS, Ortolano GA, et al. Conditioned blood reperfusion during angioplasty (COBRA) treatment of acute myocardial infarction. Perfusion. 2001;16(Suppl):39-49.
26. Forbess JM, Ibla JC, Lidov HGW, et al. University of Wisconsin cerebroplegia in a piglet survival model of circulatory arrest. Ann Thorac Surg. 1995;60(6 Suppl):S494-S500.
27. Ihnken K, Morita K, Buckberg GD, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion. J Thorac Cardiovasc Surg. 1995;110:1182-9.
28. Priestley MA, Golden JA, O'Hara IB, McCann J, Kurth CD. Comparison of neurologic outcome after deep hypothermic circulatory arrest with alpha-stat cardiopulmonary bypass in newborn pigs. J Thorac Cardiovasc Surg. 2001;336-43.
29. Rimpilainen J, Pokela M, Kiviluoma K, et al. Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: a study in a chronic porcine model. J Thorac Cardiovasc Surg. 2000;120:1131-41.
30. Bellinger DC, Wypij D, du Plessis AJ, et al. Developmental and neurologic effects of alpha-stat versus ph-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2001;121:374-83.
31. Allen BS, Ilbawi MN. Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery. Perfusion. 2001;16(Suppl):19-29.
32. Allen BS, Rahman SK, Ilbawi M, Feinberg H, Bolling KS, Kronon M. The detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg. 1997;64:1381-8.
33. Rinder CS, Gaal D, Student LA, Smith BR. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenial heart disease undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994;107:280-8.
34. Castaneda AR, Jonas RA, Mayer JE Jr, Hanley FL. Cardiopulmonary bypass, hypothermia, and circulatory arrest. In: Castaneda AR, Jonas RA, Mayer JE Jr, Hanley FL, editors. Cardiac surgery of the neonate and infant. Philadelphia: WB Saunders; 1994. p. 23-39.
35. Nollert G, Nagashima M, Bucerius J, et al. Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. II. Hypoxic versus free radical injury. J Thorac Cardiovasc Surg. 1999:117:1172-9.